Nicholas J Baumhover相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for 203Pb and 212Pb-Based Theranostics

与放射性肽结合的铅特异性螯合剂 (PSC) 对基于 203Pb 和 212Pb 的治疗诊断学的临床前评估

期刊:Pharmaceutics

影响因子:4.9

doi:10.3390/pharmaceutics15020414

Mengshi Li, Nicholas J Baumhover, Dijie Liu, Brianna S Cagle, Frédéric Boschetti, Guillaume Paulin, Dongyoul Lee, Zhiming Dai, Ephraim R Obot, Brenna M Marks, Ibrahim Okeil, Edwin A Sagastume, Moustafa Gabr, F Christopher Pigge, Frances L Johnson, Michael K Schultz

发表日期：2023

文献求助收藏

Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma

靶向α粒子放射治疗和免疫检查点抑制剂对恶性黑色素瘤肿瘤生长的协同抑制

doi:10.3390/cancers13153676

Mengshi Li, Dijie Liu, Dongyoul Lee, Yinwen Cheng, Nicholas J Baumhover, Brenna M Marks, Edwin A Sagastume, Zuhair K Ballas, Frances L Johnson, Zachary S Morris, Michael K Schultz

发表日期：2021

文献求助收藏

Synthesis and radiolabeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging

螯合剂-RNA 适体生物共轭物的合成及与铜-64 的放射性标记用于靶向分子成像

期刊:Bioorganic & Medicinal Chemistry

影响因子:3.3

doi:10.1016/j.bmc.2011.05.010

William M Rockey, Ling Huang, Kyle C Kloepping, Nicholas J Baumhover, Paloma H Giangrande, Michael K Schultz

发表日期：2011

文献求助收藏